Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

NCT00492050 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom's Macroglobulinemia

Interventions

DRUG: Bortezomib
DRUG: Rituximab
DRUG: Valacyclovir

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]